These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
257 related items for PubMed ID: 11402315
1. Induction of the AP-1 members c-Jun and JunB by TGF-beta/Smad suppresses early Smad-driven gene activation. Verrecchia F, Tacheau C, Schorpp-Kistner M, Angel P, Mauviel A. Oncogene; 2001 Apr 26; 20(18):2205-11. PubMed ID: 11402315 [Abstract] [Full Text] [Related]
2. Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner. Verrecchia F, Vindevoghel L, Lechleider RJ, Uitto J, Roberts AB, Mauviel A. Oncogene; 2001 Jun 07; 20(26):3332-40. PubMed ID: 11423983 [Abstract] [Full Text] [Related]
3. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Zhang Y, Feng XH, Derynck R. Nature; 1998 Aug 27; 394(6696):909-13. PubMed ID: 9732876 [Abstract] [Full Text] [Related]
4. 5-fluorouracil blocks transforming growth factor-beta-induced alpha 2 type I collagen gene (COL1A2) expression in human fibroblasts via c-Jun NH2-terminal kinase/activator protein-1 activation. Wendling J, Marchand A, Mauviel A, Verrecchia F. Mol Pharmacol; 2003 Sep 27; 64(3):707-13. PubMed ID: 12920208 [Abstract] [Full Text] [Related]
5. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators. Ghosh AK, Yuan W, Mori Y, Varga J. Oncogene; 2000 Jul 20; 19(31):3546-55. PubMed ID: 10918613 [Abstract] [Full Text] [Related]
6. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism. Schiller M, Verrecchia F, Mauviel A. Oncogene; 2003 Dec 04; 22(55):8881-90. PubMed ID: 14654784 [Abstract] [Full Text] [Related]
7. Stable induction of c-jun mRNA expression in normal human keratinocytes by agents that induce predifferentiation growth arrest. Blatti SP, Scott RE. Cell Growth Differ; 1992 Jul 04; 3(7):429-34. PubMed ID: 1419906 [Abstract] [Full Text] [Related]
8. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest. Paterson IC, Davies M, Stone A, Huntley S, Smith E, Pring M, Eveson JW, Robinson CM, Parkinson EK, Prime SS. Oncogene; 2002 Feb 28; 21(10):1616-24. PubMed ID: 11896591 [Abstract] [Full Text] [Related]
9. Transforming growth factor-beta induced collagenase-3 production in human osteoarthritic chondrocytes is triggered by Smad proteins: cooperation between activator protein-1 and PEA-3 binding sites. Tardif G, Reboul P, Dupuis M, Geng C, Duval N, Pelletier JP, Martel-Pelletier J. J Rheumatol; 2001 Jul 28; 28(7):1631-9. PubMed ID: 11469472 [Abstract] [Full Text] [Related]
10. The steroid receptor co-activator-1 (SRC-1) potentiates TGF-beta/Smad signaling: role of p300/CBP. Dennler S, Pendaries V, Tacheau C, Costas MA, Mauviel A, Verrecchia F. Oncogene; 2005 Mar 10; 24(11):1936-45. PubMed ID: 15688032 [Abstract] [Full Text] [Related]
11. Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation. Feinberg MW, Shimizu K, Lebedeva M, Haspel R, Takayama K, Chen Z, Frederick JP, Wang XF, Simon DI, Libby P, Mitchell RN, Jain MK. Circ Res; 2004 Mar 19; 94(5):601-8. PubMed ID: 14752027 [Abstract] [Full Text] [Related]
12. Retinoic acid receptors interfere with the TGF-beta/Smad signaling pathway in a ligand-specific manner. Pendaries V, Verrecchia F, Michel S, Mauviel A. Oncogene; 2003 Nov 06; 22(50):8212-20. PubMed ID: 14603262 [Abstract] [Full Text] [Related]
13. Functional cooperation between Smad proteins and activator protein-1 regulates transforming growth factor-beta-mediated induction of endothelin-1 expression. Rodríguez-Pascual F, Redondo-Horcajo M, Lamas S. Circ Res; 2003 Jun 27; 92(12):1288-95. PubMed ID: 12764024 [Abstract] [Full Text] [Related]
14. Dominant-negative SMAD-3 interferes with transcriptional activation by multiple agonists. Mucsi I, Goldberg HJ. Biochem Biophys Res Commun; 1997 Mar 17; 232(2):517-21. PubMed ID: 9125213 [Abstract] [Full Text] [Related]
15. TGF-beta1-induced Smad 3 binding to the Smad 7 gene: knockout of Smad 7 gene transcription by sense phosphorothioate oligos, autoregulation, and effect on TGF-beta1 secretion: bleomycin acts through TGF-beta1. Cutroneo KR, Phan SH. J Cell Biochem; 2003 Jun 01; 89(3):474-83. PubMed ID: 12761881 [Abstract] [Full Text] [Related]
16. Transforming growth factor-beta-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability. Zhu S, Goldschmidt-Clermont PJ, Dong C. Circ Res; 2004 Mar 19; 94(5):617-25. PubMed ID: 14739161 [Abstract] [Full Text] [Related]
17. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K. Oncogene; 2004 Mar 04; 23(9):1656-67. PubMed ID: 15001984 [Abstract] [Full Text] [Related]
18. JunB negatively regulates AP-1 activity and cell proliferation of malignant mouse keratinocytes. Finch S, Joseloff E, Bowden T. J Cancer Res Clin Oncol; 2002 Jan 04; 128(1):3-10. PubMed ID: 11862466 [Abstract] [Full Text] [Related]
19. Promoter-specific trans-activation and inhibition mediated by JunB. Hsu JC, Cressman DE, Taub R. Cancer Res; 1993 Aug 15; 53(16):3789-94. PubMed ID: 8339292 [Abstract] [Full Text] [Related]
20. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1. Fralix KD, Zhao S, Venkatasubbarao K, Freeman JW. J Cell Physiol; 2003 Jan 15; 194(1):88-99. PubMed ID: 12447993 [Abstract] [Full Text] [Related] Page: [Next] [New Search]